Skip to main navigation Skip to search Skip to main content

Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin

  • Ching Lun Chien (Contributor)
  • Yen-Chou Chen (Contributor)
  • Daniel C. Malone (Creator)
  • Yueh Lung Peng (Contributor)
  • Yu Ko (Creator)

Dataset

Search results